Multiple Sclerosis (MS) Market Research Reports & Industry Analysis
The prevalence rate of MS in the United States is approximately 57.8 per 100,000. Above the 37th parallel, the prevalence is reported at 68.8 per 100,000, and below it, it is reported at 35.5 per 100,000 Scientists continue their extensive efforts to create new and better therapies for MS. One of the most promising MS research areas involves naturally occurring antiviral proteins known as interferons. Beta interferon has been shown to reduce the number of exacerbations and may slow the progression of physical disability.
When attacks do occur, they tend to be shorter and less severe. In addition, there are a number of treatments under investigation that may curtail attacks or improve function. Over a dozen clinical trials testing potential therapies are underway, and additional new treatments are being devised and tested in animal models. There are a variety of treatments for M.S. which are indicated to slow the progress of the disease.
Multiple Sclerosis (MS) Industry Research & Market Reports
-
The 2023-2028 World Outlook for Beta Interferon Therapeutics for Multiple Sclerosis
... are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These ... Read More
-
Specialty Drug Distribution Market Research Report by Indication (AIDS, Hemophilia, and Multiple Sclerosis), Type, Distribution Type, Distribution Channel, State (Illinois, Pennsylvania, and Florida) - United States Forecast to 2027 - Cumulative Impact of
... The United States Specialty Drug Distribution Market size was estimated at USD 340.41 million in 2021 and expected to reach USD 386.97 million in 2022, and is projected to grow at a CAGR 13.99% to ... Read More
-
Specialty Drug Distribution Market Research Report by Indication (AIDS, Hemophilia, and Multiple Sclerosis), Type, Distribution Type, Distribution Channel, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2026 - Cumul
... Impact of COVID-19 The Global Specialty Drug Distribution Market size was estimated at USD 1,588.44 million in 2020 and expected to reach USD 1,807.37 million in 2021, and is projected to grow at a CAGR ... Read More
-
Global Autoimmune Disease Therapeutics Market: Analysis By Drug Class (Anti-inflammatory, Interferons, NSAIDs and Antihyperglycemics) By Indication (Rheumatoid Arthritis, Multiple Sclerosis, Inflammatory Bowel Disease, Type 1 Diabetes) By Region (North Am
... East & Africa, and Latin America) Size & Trends with Impact of Covid-19 and Forecast up to 2025 Scope of the Report The report provides an in depth analysis of the global autoimmune disease therapeutics ... Read More
-
Global Johnson Neuroectodermal Syndrome Market Size study, by Drug Class (Immunomodulators, Interferons, Decarboxylase Inhibitors, Dopamine Agonists and Others) by Disease Indication (Multiple Sclerosis, Parkinson’s Disease, Alzheimer's Disease, Spinal Mu
... Route of Administration (Oral, Injection, Transdermal), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Online Pharmacy) and Regional Forecasts 2022-2028 Global Johnson Neuroectodermal Syndrome Market is valued approximately USD XX billion in 2022 and is ... Read More
-
Relapsing Remitting Multiple Sclerosis- Pipeline Insight, 2022
... clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage ... Read More
-
Multiple Sclerosis Market in US 2022-2026
... during the forecast period. Our report on the multiple sclerosis market in us provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. ... Read More
-
Global Non-oncology Biopharmaceuticals Market - 2021-2028
... CAGR of XX % during the forecast period (2021-2028). Biopharmaceuticals are part of the wider category of therapeutic agents called biologics. Biopharmaceuticals are substances developed in living systems with the help of biotechnology and are ... Read More
-
Multiple Sclerosis Market Insight, Epidemiology and Market Forecast -2032
... EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Multiple Sclerosis (MS) market report provides current treatment practices, emerging drugs, market share of the individual therapies, current and forecasted Multiple Sclerosis (MS) symptoms ... Read More
-
Multiple sclerosis - Pipeline Insight, 2022
... stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global coverage Multiple sclerosis ... Read More
-
Global Neurorehabilitation Market Size study, by Type (Neuro-Robotic Devices, Non-Invasive Stimulators, and Brain-Computer Interfaces), by Application (Brain Stroke, Parkinson's Disease, Multiple Sclerosis, Spinal Cord Injury, Traumatic Brain Injury, Cere
... End-User (Rehabilitation Centers, Hospitals, and Clinics) and Regional Forecasts 2021-2027 Global Neurorehabilitation Market is valued at approximately USD 1097.69 billion in 2020 and is anticipated to grow with a healthy growth rate of more than ... Read More
-
Global Interferons Market Product Type (Interferon Alpha, Interferon Beta, Interferon Gamma), By Application (Hepatitis B, Hepatitis C, Melanoma, Leukemia, Multiple Sclerosis, Renal Cell Carcinoma), Regional Forecasts 2021-2027
... USD XX billion in 2020 and is anticipated to grow with a healthy growth rate of more than 5.7% over the forecast period 2021-2027. The interferons are biopharmaceuticals made from live creatures like microbes and ... Read More
-
Relapsing Multiple Sclerosis (RMS) - Epidemiology Forecast to 2032
... EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Relapsing Multiple Sclerosis ... Read More
-
Primary Progressive Multiple Sclerosis (PPMS) - Market Insight, Epidemiology and Market Forecast -2032
... Progressive Multiple Sclerosis (PPMS) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Primary Progressive Multiple Sclerosis (PPMS) market report provides current treatment practices, emerging drugs, Primary ... Read More
-
Secondary Progressive Multiple Sclerosis (SPMS) - Market Insight, Epidemiology and Market Forecast -2032
... Progressive Multiple Sclerosis (SPMS) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Secondary Progressive Multiple Sclerosis (SPMS) market report provides current treatment practices, emerging drugs, Secondary ... Read More
-
Targeted Therapeutics Market - By Type (Monoclonal Antibodies, Small Molecular Inhibitors, Prodrug, And Nano-Particulate Antibody Conjugates), By Application (Breast Cancer, Leukemia, Colorectal Cancer, Lymphoma, Renal Cancer, Multiple Sclerosis, Wet Age-
... Cancer), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, And Retail Pharmacies),And By Region- Global Industry Perspective, Comprehensive Analysis, And Forecast, 2021 – 2030 Market Overview Fatpos Global has released a report titled Targeted Therapeutics Market ... Read More
-
Relapsing Multiple Sclerosis (RMS) - Market Insight, Epidemiology and Market Forecast -2032
... (RMS) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Relapsing Multiple Sclerosis (RMS) market report provides current treatment practices, emerging drugs, Relapsing Multiple Sclerosis (RMS) market ... Read More
-
Chronic Progressive Multiple Sclerosis - Market Insight, Epidemiology and Market Forecast -2032
... Sclerosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Chronic Progressive Multiple Sclerosis market report provides current treatment practices, emerging drugs, Chronic Progressive Multiple Sclerosis market ... Read More
-
Global Multiple Sclerosis (MS) Market – Analysis By Drug Class, Route of Administration, Distribution Channel, By Region, By Country (2021 Edition): Market Insights, Pipeline and Forecast with Impact of COVID-19 (2021-2026)
... Global Multiple Sclerosis Market is estimated at USD 26.01 Billion in the year 2020. The introduction of disease-modifying drugs as a treatment option is a key factor that drives the growth of the global multiple ... Read More
-
Multiple Sclerosis (Central Nervous System) - Drugs in Development, 2021
... Sclerosis (Central Nervous System) pipeline landscape. Multiple sclerosis (MS) is a potentially debilitating disease in which body's immune system eats away at the protective sheath (myelin) that covers nerves. Damage to myelin causes interference in ... Read More
-
Neurorehabilitation Market by Type (Neuro-Robotic Devices, Non-Invasive Stimulators, and Brain-Computer Interfaces), Application (Brain Stroke, Parkinson's Disease, Multiple Sclerosis, Spinal Cord Injury, Traumatic Brain Injury, Cerebral Palsy, and Others
... Clinics): Global Opportunity Analysis and Industry Forecast, 2021–2030. The global neurorehabilitation market was valued at $ 1,097.69 million in 2020 and is projected to reach $ 2,451.25 million by 2030 registering a CAGR of 8.3% ... Read More
-
Blood Brain Barrier Technologies Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Technology (Bispecific Antibody RMT Approach, Trojan Horse Approach, Increasing Permeability, Passive Diffusion, and Other Non-Invasive BBB Technologies); Ap
... Disease, Epilepsy, Parkinson’s Disease, Multiple Sclerosis, Hunter’s Syndrome, Brain Cancer, and Others), and Geography The blood brain barrier technologies market is expected to reach US$ 5,101.94 million by 2028 from US$ 1,041.05 million in 2021; ... Read More
-
Global Autoinjectors Market (4th Edition), 2021-2035 Distribution by Type of Autoinjector (Disposable and Reusable), Route of Administration (Subcutaneous and Intramuscular), Type of Molecule (Monoclonal Antibody, Peptide, Protein, and Small Molecule), Th
... Sclerosis, Rheumatoid Arthritis, Migraine, Diabetes, and Others) and Geography (North America, Europe, Asia-Pacific, and Rest of the World): Industry Trends and Global Forecasts According to the National Health Interview Survey (NHIS), nearly 52% of the ... Read More
-
Global Neurological Biomarkers Market Size study, by Application (Alzheimer’s, Parkinson’s, Multiple Sclerosis, Autism Spectrum Disorder, Others), By Type (Genomic, Proteomic, Metabolomic, Imaging, Others), By End-use (Hospital & Hospital Laboratories, In
... Organizations and Others) and Regional Forecasts 2021-2027 Global Neurological Biomarkers Market is valued approximately USD 6.1 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 12.9% over the ... Read More
-
Multiple Sclerosis Drugs Global Market Report 2021: COVID-19 Growth And Change To 2030
... marketers and senior management with the critical information they need to assess the global multiple sclerosis drugs market. This report focuses on multiple sclerosis drugs market which is experiencing strong growth. The report gives a ... Read More
Research Assistance
